The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment
Molecules · 2024
DOI: 10.3390/molecules29122727 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Yan Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine…. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Colorectal Neoplasms, Signal Transduction, Biological Products. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province, Key Projects of Science and Technology Plan of Inner Mongolia Autonomous Region.
Abstract (Originalsprache)
The toll-like receptor 4 (TLR4) signaling pathway constitutes an intricate network of protein interactions primarily involved in inflammation and cancer. This pathway triggers intracellular signaling cascades, modulating transcription factors that regulate gene expression related to immunity and malignancy. Previous studies showed that colon cancer patients with low TLR4 expression exhibit extended survival times and the TLR4 signaling pathway holds a significant role in CRC pathogenesis. In recent years, traditional Chinese medicines (TCMs) have garnered substantial attention as an alternative therapeutic modality for CRC, primarily due to their multifaceted composition and ability to target multiple pathways. Emerging evidence indicates that specific TCM products, such as andrographolide, rosmarinic acid, baicalin, etc., have the potential to impede CRC development through the TLR4 signaling pathway. Here, we review the role and biochemical processes of the TLR4 signaling pathway in CRC, and natural products from TCMs affecting the TLR4 pathway. This review sheds light on potential treatment strategies utilizing natural TLR4 inhibitors for CRC, which contributes to the advancement of research and accelerates their clinical integration into CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
ORCID-Profile: Yan Luo, Guochen Zhang, Chao Hu, Lijun Huang, Dong Wang, Zhejie Chen, Yumei Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
- Key Projects of Science and Technology Plan of Inner Mongolia Autonomous Region
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- China Postdoctoral Science Foundation
Zitieren
APA
Luo, Y., Zhang, G., Hu, C., Huang, L., Wang, D., Chen, Z., & Wang, Y. (2024). The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment. Molecules. https://doi.org/10.3390/molecules29122727
Vancouver
Luo Y, Zhang G, Hu C, Huang L, Wang D, Chen Z, et al. The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment. Molecules. 2024. doi:10.3390/molecules29122727
BibTeX
@article{Luo2024,
author = {Luo, Yan and Zhang, Guochen and Hu, Chao and Huang, Lijun and Wang, Dong and Chen, Zhejie and Wang, Yumei},
title = {The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29122727}
}
EUVIMED